These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22065948)

  • 1. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.
    Beaulieu JM; Del'guidice T; Sotnikova TD; Lemasson M; Gainetdinov RR
    Front Mol Neurosci; 2011; 4():38. PubMed ID: 22065948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/GSK3 signaling in the action of psychotropic drugs.
    Beaulieu JM; Gainetdinov RR; Caron MG
    Annu Rev Pharmacol Toxicol; 2009; 49():327-47. PubMed ID: 18928402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.
    Del'guidice T; Lemasson M; Beaulieu JM
    Front Neuroanat; 2011; 5():58. PubMed ID: 21922001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Akt-GSK-3 signaling cascade in the actions of dopamine.
    Beaulieu JM; Gainetdinov RR; Caron MG
    Trends Pharmacol Sci; 2007 Apr; 28(4):166-72. PubMed ID: 17349698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physiology, signaling, and pharmacology of dopamine receptors.
    Beaulieu JM; Gainetdinov RR
    Pharmacol Rev; 2011 Mar; 63(1):182-217. PubMed ID: 21303898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of GSK3 by lithium, from single molecules to signaling networks.
    Freland L; Beaulieu JM
    Front Mol Neurosci; 2012 Jan; 5():14. PubMed ID: 22363263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.
    Beaulieu JM
    J Psychiatry Neurosci; 2012 Jan; 37(1):7-16. PubMed ID: 21711983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single or combined treatment with L-DOPA and quinpirole differentially modulate expression and phosphorylation of key regulatory kinases in neuroblastoma cells.
    Fuzzati-Armentero MT; Ghezzi C; Nisticò R; Oda A; Blandini F
    Neurosci Lett; 2013 Sep; 552():168-73. PubMed ID: 23896526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β activity and hyperdopamine-dependent behaviors.
    Li YC; Gao WJ
    Neurosci Biobehav Rev; 2011 Jan; 35(3):645-54. PubMed ID: 20727368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses].
    Del'Guidice T; Beaulieu JM
    Med Sci (Paris); 2010; 26(6-7):647-51. PubMed ID: 20619169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.
    Roh MS; Seo MS; Kim Y; Kim SH; Jeon WJ; Ahn YM; Kang UG; Juhnn YS; Kim YS
    Exp Mol Med; 2007 Jun; 39(3):353-60. PubMed ID: 17603289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.
    Beaulieu JM; Tirotta E; Sotnikova TD; Masri B; Salahpour A; Gainetdinov RR; Borrelli E; Caron MG
    J Neurosci; 2007 Jan; 27(4):881-5. PubMed ID: 17251429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity.
    Chatterjee D; Beaulieu JM
    Front Mol Neurosci; 2022; 15():1028963. PubMed ID: 36504683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae.
    Souza BR; Romano-Silva MA; Tropepe V
    J Neurosci; 2011 Apr; 31(14):5512-25. PubMed ID: 21471388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of PKA/DARPP-32/PP1α and β- arrestin/Akt/GSK-3β Signaling in Cadmium-Induced DA-D2 Receptor-Mediated Motor Dysfunctions: Protective Role of Quercetin.
    Gupta R; Shukla RK; Pandey A; Sharma T; Dhuriya YK; Srivastava P; Singh MP; Siddiqi MI; Pant AB; Khanna VK
    Sci Rep; 2018 Feb; 8(1):2528. PubMed ID: 29410441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
    Deslauriers J; Desmarais C; Sarret P; Grignon S
    J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation.
    Chen HT; Ruan NY; Chen JC; Lin TY
    ASN Neuro; 2012 Sep; 4(6):371-82. PubMed ID: 22909302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A beta-arrestin 2 signaling complex mediates lithium action on behavior.
    Beaulieu JM; Marion S; Rodriguiz RM; Medvedev IO; Sotnikova TD; Ghisi V; Wetsel WC; Lefkowitz RJ; Gainetdinov RR; Caron MG
    Cell; 2008 Jan; 132(1):125-36. PubMed ID: 18191226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.
    Beaulieu JM; Sotnikova TD; Marion S; Lefkowitz RJ; Gainetdinov RR; Caron MG
    Cell; 2005 Jul; 122(2):261-73. PubMed ID: 16051150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.